Literature DB >> 26256943

Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations.

Harrys A Torres1, Pearlie P Chong2, Marcos De Lima3, Mark S Friedman4, Sergio Giralt5, Sarah P Hammond6, Patrick J Kiel7, Henry Masur8, George B McDonald9, John R Wingard10, Maya Gambarin-Gelwan5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26256943     DOI： 10.1016/j.bbmt.2015.07.033

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  11 in total

1.  Treatment of hepatitis C in a pediatric patient using simeprevir and sofosbuvir immediately after an umbilical cord blood transplantation.

Authors:  P Thomas; T Santiago; M H Dallas
Journal:  Bone Marrow Transplant       Date:  2016-01-11       Impact factor: 5.483

2.  Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer.

Authors:  M P Economides; P Mahale; A Kyvernitakis; F Turturro; H Kantarjian; A Naing; J Hosry; T L Shigle; A Kaseb; H A Torres
Journal:  Aliment Pharmacol Ther       Date:  2016-10-11       Impact factor: 8.171

3.  Severe hepatitis C reactivation as an early complication of hematopoietic cell transplantation.

Authors:  N T Oliver; Y L Nieto; B Blechacz; P Anderlini; E Ariza-Heredia; H A Torres
Journal:  Bone Marrow Transplant       Date:  2016-07-18       Impact factor: 5.483

4.  Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.

Authors:  Andreas Kyvernitakis; Parag Mahale; Uday R Popat; Ying Jiang; Jeff Hosry; Richard E Champlin; Harrys A Torres
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-19       Impact factor: 5.742

5.  Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study.

Authors:  Harrys A Torres; Jeff Hosry; Parag Mahale; Minas P Economides; Ying Jiang; Anna S Lok
Journal:  Hepatology       Date:  2017-11-13       Impact factor: 17.425

Review 6.  The oncologic burden of hepatitis C virus infection: A clinical perspective.

Authors:  Harrys A Torres; Terri Lynn Shigle; Nassim Hammoudi; James T Link; Felipe Samaniego; Ahmed Kaseb; Vincent Mallet
Journal:  CA Cancer J Clin       Date:  2017-07-06       Impact factor: 508.702

7.  How I treat hepatitis C virus infection in patients with hematologic malignancies.

Authors:  Harrys A Torres; George B McDonald
Journal:  Blood       Date:  2016-07-21       Impact factor: 22.113

8.  Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study.

Authors:  Harrys A Torres; Anna S Lok; Maria E Suarez-Almazor; Carla L Warneke; Ahmed Kaseb; Ethan Miller; Erich M Sturgis; Jessica T Foreman; Georgios Angelidakis; Sairah Ahmed; Alessandra Ferrajoli; Felipe Samaniego; Ernest T Hawk; Jessica P Hwang
Journal:  Support Care Cancer       Date:  2020-04-20       Impact factor: 3.603

Review 9.  Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy.

Authors:  Dimitrios C Ziogas; Frosso Kostantinou; Evangelos Cholongitas; Amalia Anastasopoulou; Panagiotis Diamantopoulos; John Haanen; Helen Gogas
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

10.  Management of Multiple Myeloma Complicated by Hepatitis C Virus Reactivation: The Role of New Antiviral Therapy.

Authors:  Parag Mahale; Sheeba K Thomas; Andreas Kyvernitakis; Harrys A Torres
Journal:  Open Forum Infect Dis       Date:  2015-12-28       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.